NAT10 and cancer: During the temporal stage of tumorigenesis, the function of NAT10 may shift from protective (e.g., maintaining genomic stability in premalignant cells) to pro-oncogenic (e.g., driving proliferation and therapy resistance in established cancers) during disease progression.